Literature DB >> 511154

Genetics and biochemistry of the phenylketonuria-present state.

K Bartholomé.   

Abstract

Phenylketonuria is an autosomal recessive inherited disease caused by a disturbance in the phenylalanine hydroxylating system. Phenylalanine is converted to tyrosine by phenylalanine hydroxylase, which is located mainly in the liver. This enzyme needs the reduced cofactor tetrahydrobiopterin to be active. In phenylketonuria, low or zero enzyme activity is measured. Enzyme activity higher than 5% compared with that in normal controls is correlated to hyperphenylalaninemia. Dihydropteridine reductase regenerates the active cofactor. A defect in this enzyme or in the biosynthesis of the cofactor results in phenylketonuria which does not respond to dietary treatment because the biosynthesis of neurotransmitters is impaired.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511154     DOI: 10.1007/bf00283389

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  Phenylketonuria due to a deficiency of dihydropteridine reductase.

Authors:  S Kaufman; N A Holtzman; S Milstien; L J Butler; A Krumholz
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

2.  Influence of phenylalanine intake on phenylketonuria.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Lancet       Date:  1953-10-17       Impact factor: 79.321

3.  Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system.

Authors:  G A JERVIS
Journal:  Proc Soc Exp Biol Med       Date:  1953-03

4.  Enzyme activity in classical and variant forms of maple syrup urine disease.

Authors:  J Dancis; J Hutzler; S E Snyderman; R P Cox
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

5.  Clinical and biochemical observations of patients with atypical phenylketonuria.

Authors:  E S Kang; S Kaufman; P S Gerald
Journal:  Pediatrics       Date:  1970-01       Impact factor: 7.124

6.  Letter: A new molecular defect in phenylketonuria.

Authors:  K Bartholome
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

7.  Letter: L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity.

Authors:  K Bartholomé; D J Byrd
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

8.  [Phenylalanine hydroxylase activity in heterozygote hereditary carriers of the phenylketonuria gene].

Authors:  U Grimm; A Knapp; K Schlenzka; R Hesse
Journal:  Acta Biol Med Ger       Date:  1977

9.  A third allele at the phenylalanine-hydroxylase locus in mild phenylketonuria (hyperphenylalaninaemia).

Authors:  L I Woolf; B L Goodwin; W I Cranston; D N Wade; F Woolf; F P Hudson; M S McBean
Journal:  Lancet       Date:  1968-01-20       Impact factor: 79.321

10.  Atypical phenylketonuria caused by 7, 8-dihydrobiopterin synthetase deficiency.

Authors:  A Niederwieser; H C Curtius; O Bettoni; J Bieri; B Schircks; M Viscontini; J Schaub
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321

View more
  4 in total

Review 1.  The salience of Garrod's 'molecular groupings' and 'Inborn Factors in Disease'.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Expression of human phenylalanine hydroxylase activity in T lymphocytes of classical phenylketonuria children by retroviral-mediated gene transfer.

Authors:  C M Lin; Y Tan; Y M Lee; C C Chang; K J Hsiao
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

3.  Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase.

Authors:  J D McDonald; V C Bode; W F Dove; A Shedlovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Incidence of phenylketonuria (PKU) in Iran.

Authors:  D D Farhud; M Kabiri
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.